RoyOMartin
RoyOMartin is a group of family-owned, professionally managed forestry and wood-products manufacturing companies based in Alexandria, LA.
Martco L.L.C., known by its trade name RoyOMartin (“ROM”), is one of a group of vertically integrated companies owned by the Martin family focused on land, timber, and mineral resources, with special emphasis on sustainable forests and forest-product manufacturing businesses. The RoyOMartin name honors the business pioneer and Martin family patriarch, Roy O. Martin Sr., who began with a small sawmill in Alexandria, Louisiana, in 1923, and soon thereafter bought a few acres of timberland.
RoyOMartin OSB - Oakdale Hosts the American Loggers Council
RoyOMartin is Building the Future of Wood Products Manufacturing
Tuffstrand® WRB is Now Available from RoyOMartin
Grand Opening of the Largest OSB Facility in North America | feat. Greg Abbott, Texas Governor
Tour the Largest OSB Manufacturing Facility in North America
Inside Our Plywood and Timbers Mill | Full Manufacturing Process Revealed
A Day in the Life of a Production Team Member at an OSB Mill | RoyOMartin Job Profiles
A BROTHERHOOD STORY
Alonso Turns His Life Around
IBiZ NOW Means Zero Accidents and Zero Injuries
We are Plywood Proud in Chopin, Louisiana
Rodney Goes Full Circle in Forestry
RoyOMartin Appreciates our Logging Contractors
RoyOMartin Participates in Manufacturing Month
Justin Washington Gets a Second Chance
Brenda Marks 47 Years with RoyOMartin
Woodworks Signing Day 2022
How RoyOMartin Makes Oriented Strand Board (OSB)
Brandon Grows His Career
Board Certified with Zach Zimmerman - OSB vs Flexible Sheathing
Board Certified with Zach Zimmerman - WindBrace OSB Wall Sheathing
Savannah Meyring Discovers Fresh Start With a New Career in Manufacturing
Board Certified with Zach Zimmerman - Eclipse OSB Radiant Barrier
Manufacturing Production Career Pays Off for Team Member Sharon Wells
RoyOMartin OSB Process Presentation
Dr. Brian Elkins Recommends the COVID Vaccine
One Team, One Dream
A medical doctor answers common questions about the Covid-19 vaccine